Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 18, 2023

BUY
$4.3 - $7.78 $860,000 - $1.56 Million
200,000 Added 77.55%
457,892 $2.43 Million
Q3 2022

Nov 08, 2022

BUY
$5.34 - $12.79 $1.37 Million - $3.28 Million
256,514 Added 18614.95%
257,892 $2.72 Million
Q2 2022

Aug 16, 2022

BUY
$5.1 - $9.74 $7,027 - $13,421
1,378 New
1,378 $255 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.